Adverse Drug Events Reporting News

 

Adverse Drug Events Reporting Perspective

  • LDL and Stroke Prevention: How Low to Go   Dr Christoph Diener reviews a new study looking at cholesterol management in secondary stroke prevention, plus other recent studies in neurology.
  • Could Colchicine Be the New Aspirin? Michel Zeitouni talks to Jean-Claude Tardif about the COLCOT series of clinical trials testing colchicine, an anti-inflammatory gout drug, for the prevention and treatment of cardiovascular disease.
 

Adverse Drug Events Reporting Journal Articles